Table 1. The relationship between OLC1 expression and patient clinicopathological characteristics.
Expression of OLC1 protein | Total Patients | Percent positive (%) | P value* | |||
(−)(±)# | (+)# | (++)# | ||||
General | ||||||
Normal Adjacent tissue | 155 | 51 | 8 | 214 | 27.57 | |
Tumor tissue | 69 | 115 | 30 | 214 | 67.80 | <0.001 |
Gender | ||||||
Male | 54 | 93 | 25 | 172 | ||
Female | 16 | 21 | 5 | 42 | >0.05 | |
Age | ||||||
<60 | 41 | 68 | 14 | 123 | ||
≥60 | 29 | 46 | 16 | 91 | >0.05 | |
TNM Stage | ||||||
T3N0M0 | 38 | 54 | 12 | 104 | 63.46 | |
T3N1M0 | 32 | 60 | 18 | 110 | 70.91 | >0.05 |
(−) = no staining; (±) = background or faint staining; (+) = positive staining; (++) = intense staining. Samples marked (+) or (++) were considered positive for OLC1 protein expression.
*Significance was determined by Pearson chi-square test.